IP Library Granted Patent US 7,972,820
Granted Patent B2
US 7,972,820 · App. 12/774,126 · Granted Jul 5, 2011

Isothermal amplification of nucleic acids on a solid support

Assignees: Illumina Cambridge Limited; Illumina, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,972,820
App. No.
12/774,126
Granted
Jul 5, 2011
Kind
B2
Abstract

Methods for isothermal amplification of nucleic acids by the means of a solid support are disclosed. These methods are useful for applications needing high throughput, in particular nucleic acid sequencing.

Claims (27)

1. A method for amplifying nucleic acid molecules comprising:

a) providing a plurality of immobilized first single stranded nucleic acid molecules and a plurality of immobilized primers, wherein the plurality of immobilized primers comprises first and second primers;

b) allowing the immobilized first single stranded nucleic acid molecules to anneal to first primers of the plurality of immobilized primers;

c) extending the annealed first primers using the first single stranded nucleic acid molecules as templates to generate double stranded nucleic acid molecules comprising immobilized first and second single stranded nucleic acid molecules;

d) denaturing the double stranded nucleic acid molecules to separate the immobilized first and second single stranded nucleic acid molecules;

e) annealing the first single stranded nucleic acid molecules to first primers of the plurality of immobilized primers and annealing the second single stranded nucleic acid molecules to second primers of the plurality of immobilized primers;

f) extending the annealed first and second primers using the first and second single stranded nucleic acid molecules as templates to generate double stranded nucleic acid molecules; and

g) repeating steps d-f to generate multiple copies of the nucleic acid molecules, wherein steps d-f are performed at the same temperature.

2. The method of claim 1 , wherein the first single stranded nucleic acid molecules comprise common sequences at the 5′ and 3′ ends.

3. The method of claim 2 , wherein the first single stranded nucleic acid molecules comprise a common sequence Y at the 5′ end and a common sequence Z at the 3′ end.

4. The method of claim 3 , wherein the primers comprise sequence X, which is hybridizable to sequence Z.

5. The method of claim 4 , wherein the primer sequence X is the same as sequence Y.

6. The method of claim 1 , wherein the first primers comprise sequence X′ and the second primers comprise sequence X″.

7. The method of claim 6 , wherein sequence X′ is hybridizable to sequence Z.

8. The method of claim 7 , wherein the second single stranded nucleic acid molecules comprise a sequence at the 3′ end that is hybridizable to the second primers.

9. The method of claim 1 , wherein the nucleic acid molecules and primers are immobilized on a solid surface.

10. The method of claim 9 , wherein step (g) produces colonies of different nucleic acid molecules.

11. The method of claim 1 , wherein the colonies are generated at a density of 1000-100000 per mm 2 .

12. The method of claim 1 , wherein either or both of the first and second primers comprise a modification that facilitates release of at least a portion of the primer.

13. The method of claim 1 , further comprising releasing one or more of the immobilized first or second single stranded nucleic acid molecules.

14. The method of claim 1 , further comprising determining the sequence of one or more of the first or second nucleic acid molecules.

15. The method of claim 14 , wherein the sequence is determined by incorporation of labeled nucleotides.

16. The method of claim 15 , wherein the labeled nucleotides are incorporated onto the immobilized primers.

17. The method of claim 15 , wherein the labeled nucleotides are incorporated onto non-immobilized primers hybridized to the first or second single stranded nucleic acid molecules.

18. The method of claim 15 , wherein the label is a fluorescent group or a radioactive label.

19. The method of claim 14 , wherein the sequence is determined by incorporation of labeled oligonucleotides.

20. The method of claim 19 , wherein the label is a fluorescent group or a radioactive label.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2011
From: MAYER, PASCAL
To: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
Reel/Frame 026323/0597 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2011
From: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.
To: SOLEXA LTD.; LYNX THERAPEUTICS, INC.
Reel/Frame 026323/0610 →
CHANGE OF NAME Recorded May 23, 2011
From: SOLEXA LIMITED
To: ILLUMINA CAMBRIDGE LIMITED
Reel/Frame 026324/0601 →
MERGER Recorded May 23, 2011
From: SOLEXA, INC.
To: ILLUMINA, INC.
Reel/Frame 026324/0621 →
CHANGE OF NAME Recorded May 23, 2011
From: LYNX THERAPEUTICS, INC.
To: SOLEXA, INC.
Reel/Frame 026325/0563 →
Priority Claims (1)
EP 00127011 · Dec 8, 2000 · regional
Continuity (2)
Continuation 10433965
Related Publication 20110008781A1 · Jan 13, 2011